# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-014896
Filing Date
2025-04-22
Accepted
2025-04-22 16:00:22
Documents
14
Period of Report
2025-06-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20042616x1_def14a.htm iXBRL | DEF 14A | 589128
3 |  | ny20042616x1_pc01.jpg | GRAPHIC | 654796
4 |  | ny20042616x1_pc02.jpg | GRAPHIC | 561973
| Complete submission text file | 0001140361-25-014896.txt |  | 3983538

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | INLINE XBRL TAXONOMY EXTENSION - SCHEMA | npce-20250606.xsd | EX-101.SCH | 2131
16 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20042616x1_def14a_htm.xml | XML | 5181

Mailing Address 455 N. BERNARDO AVENUE MOUNTAIN VIEW CA 94043
Business Address 455 N. BERNARDO AVENUE MOUNTAIN VIEW CA 94043 6502372700
NeuroPace Inc (Filer) CIK: 0001528287 (see all company filings)

EIN.: 223550230 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40337 | Film No.: 25857650
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)